United States Bariatric Surgery Devices Market Outlook to 2025 - Gastric Balloons and Gastric Bands

1.1 List of Tables
1.2 List of Figures

2.1 What Is This Report About?
2.2 Bariatric Surgery Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report

3.1 Bariatric Surgery Devices Market, United States, Revenue ($m), 2015-2025
3.2 Bariatric Surgery Devices Market, United States, Volume (Units), 2015-2025
3.3 Bariatric Surgery Devices Market, United States, Average Price ($), 2015-2025
3.4 Bariatric Surgery Devices Market, United States, Distribution Share by Revenue ($m), 2019
3.5 Bariatric Surgery Devices Market, United States, Company Share by Revenue ($m), 2019

4.1 ReShape Lifesciences Inc
4.1.1 Company Overview
4.2 Obalon Therapeutics Inc
4.2.1 Company Overview
4.3 Apollo Endosurgery Inc
4.3.1 Company Overview

6.1 Debt Offerings
6.1.1 Boston Scientific Raises USD1.2 Billion in Public Offering of 2.65% Senior Notes due 2030
6.1.2 Boston Scientific Raises USD500 Million in Public Offering of 1.9% Senior Notes due 2025
6.1.3 Boston Scientific Raises USD999.2 Million in Public Offering of 0.625% Notes Due 2027
6.1.4 GI Dynamics to up to Raise USD4.6 Million in Private Placement of Convertible Note and Warrant
6.1.5 Apollo Endosurgery Raises USD20 Million in Private Placement of 6% Convertible Debentures Due 2024
6.2 Equity Offerings
6.2.1 Boston Scientific Raises USD1 Billion in Public Offering of Shares
6.2.2 Boston Scientific Raises USD1 Billion in Public Offering of 5.5% Mandatory Convertible Preferred Stock
6.2.3 Drive DeVilbiss Healthcare Raises USD35 Million in Financing Round
6.2.4 GI Dynamics Raises USD2 Million in First Tranche of Private Placement of CHESS Depositary Interests, upon Exercise of Warrants
6.2.5 ReShape Lifesciences to Raise USD8 Million in Private Placement of Common Stock
6.3 Private Equity
6.3.1 Obalon Therapeutics to Raise up to USD15 Million in Financing
6.3.2 Gelesis Raises USD63.4 Million in Financing

7.1 Corporate Communications
7.1.1 Dec 16, 2019: Jean-Claude Dubacher named Chairman and Chief Executive Officer of B. Braun Medical
7.1.2 Dec 03, 2019: Dr. John Halamka named president of Mayo Clinic Platform
7.1.3 Nov 20, 2019: GI Dynamics: Appointment of an Observer to the Board of Directors Representing Crystal Amber
7.1.4 Nov 03, 2019: Saint Barnabas Medical Center names new Vice President of Operations
7.1.5 Oct 30, 2019: ReShape Lifesciences appoints Thomas Stankovich as Chief Financial Officer
7.1.6 Oct 24, 2019: Obalon appoints William J. Plovanic as Chief Executive Officer and Nooshin Hussainy as Chief Financial Officer
7.1.7 Oct 24, 2019: Saint Barnabas Medical Center appoints New Chief Nursing Officer
7.1.8 Sep 03, 2019: Obalon engages Helmuth T. Billy, MD as Medical Director for its first company-owned weight loss treatment center
7.1.9 Aug 06, 2019: ReShape Lifesciences announces CFO resignation
7.1.10 Jul 24, 2019: Former Medtronic Executive Sean Ginney named VP of Sales at Current Health
7.1.11 Jun 27, 2019: TriSalus Life Sciences forms world-class scientific advisory board to accelerate advancement of strategy to deliver therapeutics to solid tumors
7.2 Financial Announcements
7.2.1 Feb 27, 2020: Obalon announces fourth quarter and full year 2019 financial results
7.2.2 Feb 05, 2020: Boston Scientific announces results for fourth quarter and full year 2019
7.2.3 Jan 14, 2020: Boston Scientific announces preliminary unaudited sales for the fourth quarter and full year 2019
7.2.4 Nov 14, 2019: ReShape Lifesciences announces third quarter 2019 financial results
7.2.5 Nov 08, 2019: Obalon announces third quarter 2019 financial results
7.2.6 Oct 30, 2019: Apollo Endosurgery reports third quarter 2019 results
7.2.7 Oct 23, 2019: Boston Scientific announces results for third quarter 2019
7.2.8 Jul 24, 2019: Boston Scientific announces results for second quarter 2019
7.2.9 Jul 24, 2019: Obalon announces second quarter 2019 financial results
7.2.10 Jul 23, 2019: Apollo Endosurgery reports second quarter 2019 results
7.3 Government and Public Interest
7.3.1 Sep 05, 2019: FDA solicits public feedback on discussion paper as part of efforts to provide clarity and transparency on how it evaluates benefits and risks of weight-loss devices
7.4 Other Significant Developments
7.4.1 May 11, 2020: Obalon announces further impacts related to covid-19 crisis and current business environment
7.4.2 Apr 14, 2020: BioCardia announces litigation financing in the case captioned Boston Scientific
7.4.3 Feb 24, 2020: AbbVie announces extension of expiration date for exchange offers for Allergan notes
7.4.4 Jan 07, 2020: Jant Pharmacal is awarded contract from Vizient
7.4.5 Aug 28, 2019: Boston Scientific Celebrates 15th Anniversary in Costa Rica
7.4.6 Jul 31, 2019: GI Dynamics: Quarter Ended 30 June 2019
7.4.7 Jul 01, 2019: Vizient announces 26 new, renewed or expanded member agreements in Q1 of 2019
7.5 Product News
7.5.1 Feb 04, 2020: Vizient to participate in FI HFMA & CHEF’s 2020 Managed Care Symposium
7.6 Strategy And Business Planning
7.6.1 Feb 12, 2020: Sanford announces new Bemidji heart center
7.6.2 Jun 24, 2019: Boston Scientific Galway expands in to new facility

8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 The Publisher's Consulting
8.3 Contact
8.4 Disclaimer

Table 1: Bariatric Surgery Devices Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 2: Bariatric Surgery Devices Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 3: Bariatric Surgery Devices Market, United States, Volume (Units), 2015-2020
Table 4: Bariatric Surgery Devices Market, United States, Volume (Units), 2021-2025
Table 5: Bariatric Surgery Devices Market, United States, Average Price ($), 2015-2020
Table 6: Bariatric Surgery Devices Market, United States, Average Price ($), 2021-2025
Table 7: Bariatric Surgery Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2019
Table 8: Bariatric Surgery Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2019
Table 9: Bariatric Surgery Devices Market Pipeline Products
Table 10: Boston Scientific Raises USD1.2 Billion in Public Offering of 2.65% Senior Notes due 2030
Table 11: Boston Scientific Raises USD500 Million in Public Offering of 1.9% Senior Notes due 2025
Table 12: Boston Scientific Raises USD999.2 Million in Public Offering of 0.625% Notes Due 2027
Table 13: GI Dynamics to up to Raise USD4.6 Million in Private Placement of Convertible Note and Warrant
Table 14: Apollo Endosurgery Raises USD20 Million in Private Placement of 6% Convertible Debentures Due 2024
Table 15: Boston Scientific Raises USD1 Billion in Public Offering of Shares
Table 16: Boston Scientific Raises USD1 Billion in Public Offering of 5.5% Mandatory Convertible Preferred Stock
Table 17: Drive DeVilbiss Healthcare Raises USD35 Million in Financing Round
Table 18: GI Dynamics Raises USD2 Million in First Tranche of Private Placement of CHESS Depositary Interests, upon Exercise of Warrants
Table 19: ReShape Lifesciences to Raise USD8 Million in Private Placement of Common Stock
Table 20: Obalon Therapeutics to Raise up to USD15 Million in Financing
Table 21: Gelesis Raises USD63.4 Million in Financing
Table 22: Total Number of Primary Research Participants, General Surgery Market, by Country

Figure 1: Bariatric Surgery Devices Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 2: Bariatric Surgery Devices Market, United States, Volume (Units), 2015-2025
Figure 3: Bariatric Surgery Devices Market, United States, Company Share (%) 2019